Your browser doesn't support javascript.
loading
Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus.
Park, Jung M; Kim, Min J; Han, Jae S; Park, So Y; Park, Shi N.
Affiliation
  • Park JM; Department of Otorhinolaryngology-Head and Neck Surgery, Gangneung Asan Hospital, College of Medicine University of Ulsan, Gangneung, Republic of Korea.
  • Kim MJ; Department of Otolaryngology-Head and Neck Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Han JS; Department of Otolaryngology-Head and Neck Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park SY; Department of Otolaryngology-Head and Neck Surgery, Yeouido St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Park SN; Department of Otolaryngology-Head and Neck Surgery, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Otolaryngol Head Neck Surg ; 169(2): 348-357, 2023 08.
Article in En | MEDLINE | ID: mdl-36939389
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tinnitus / Botulinum Toxins, Type A Type of study: Clinical_trials Limits: Animals / Humans / Male Language: En Journal: Otolaryngol Head Neck Surg Journal subject: OTORRINOLARINGOLOGIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tinnitus / Botulinum Toxins, Type A Type of study: Clinical_trials Limits: Animals / Humans / Male Language: En Journal: Otolaryngol Head Neck Surg Journal subject: OTORRINOLARINGOLOGIA Year: 2023 Document type: Article